Establishment of an in vitro aerobic bacterial community as a model of the human lung microbiome.

A stable 10-day in vitro lung microbiome model was established using four bacterial species, providing a controlled platform for respiratory microbiome research.

• Why it matters: The lung microbiome's role in drug metabolism and respiratory health is underexplored, and understanding microbial interactions is crucial for advancing disease treatment and prevention.
• What they did: Researchers developed a reproducible model with Pseudomonas koreensis, Rothia aeria, Neisseria cinerea, and Streptococcus downei, validated by PCR, microbiological methods, and bioinformatics.
• The result: This model enables detailed studies of microbial interactions and their influence on lung health, serving as a foundation for testing therapeutic strategies and understanding disease mechanisms.